Adamax

Adamax is a synthetic dipeptide analogue corresponding to a loop 4 region fragment of brain-derived neurotrophic factor (BDNF), with a molecular weight of approximately 194.2 Da. Structurally derived from the BDNF sequence, Adamax was developed as a low-molecular-weight peptidomimetic research tool for studying TrkB receptor signaling and BDNF pathway biology in CNS research models.

Published research has studied Adamax in the context of TrkB receptor activation, downstream MAPK/ERK and PI3K/Akt signaling pathway modulation, and neuroprotective mechanisms in preclinical in vitro and in vivo models — with findings suggesting effects on neuronal survival signaling, synaptic plasticity markers, and hippocampal function in animal models. These findings derive from laboratory study and do not describe or imply any effect in humans or animals outside of controlled research conditions.

Research has examined Adamax alongside other CNS-active peptide research tools including Semax (ACTH-derived neuropeptide studied for BDNF upregulation) and Dihexa (HGF/MET signaling potentiator) for comparative neurotrophic pathway research. For further reading see: BDNF peptidomimetic and TrkB signaling research (PubMed).

Specifications:

• Purity: >=99% (HPLC verified)
• Form: Lyophilized powder
• Storage: −20°C

For Research Use Only. Not for human or animal consumption.